Posted On: 12/12/2013 9:47:53 AM
Post# of 89082
$CELGZ Up to date company activities and other important information about $CELGZ
$CELGZ
DD Notes ~ http://www.ddnotesmaker.com/CELGZ
##### recent news/filings ~ source: finance.yahoo.com
Wed, 11 Dec 2013 00:32:11 GMT ~ Studies Evaluating REVLIMID® (Lenalidomide) in Lymphoma Presented at ASH
- Two studies detail R2CHOP in elderly untreated patients and R2 as maintenance in patients with diffuse large B-cell lymphoma Third study evaluated R2 in previously-treated patients with indolent or mantle ...
read full: http://www.noodls.com/view/4474EF18497823644E...DD2A39710B
*********************************************************
Tue, 10 Dec 2013 14:11:09 GMT ~ Two Studies Highlight Retrospective Analyses of Phase III Study of POMALYST®/IMNOVID® (Pomalidomide) in Previously Treated Multiple Myeloma Patients Presented at ASH
- Studies evaluated effects of high-risk cytogenetics and prior therapies on outcomes BOUDRY, Switzerland--(BUSINESS WIRE)--Dec. 10, 2013-- Celgene International Sàrl, a wholly-owned subsidiary of Celgene ...
read full: http://www.noodls.com/view/E4CD928E2815561B07...6548927AA3
*********************************************************
Tue, 10 Dec 2013 01:41:33 GMT ~ REVLIMID® (lenalidomide)-Treated Patients with Deletion-5q MDS Who Achieve Transfusion-Independence of At Least 26 Weeks and AML-Free Survival Associated with Cytogenetic Response
- Retrospective analysis presented at American Society of Hematology annual meeting BOUDRY, Switzerland--(BUSINESS WIRE)--Dec. 9, 2013-- Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation ...
read full: http://www.noodls.com/view/4FB0753A257498D89E...3334BD9AE3
*********************************************************
Sun, 08 Dec 2013 03:33:10 GMT ~ First Analysis of Extended Dosing with Celgene Epigenetic Agent CC-486 in Patients with Higher-Risk Myelodysplastic Syndromes Presented at ASH
- BOUDRY, Switzerland--(BUSINESS WIRE)--Dec. 7, 2013-- Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG) today announced that results from an ad hoc analysis of a ...
read full: http://www.noodls.com/view/512000B61C7AA8DC53...A2DF7DA0A1
*********************************************************
Fri, 22 Nov 2013 13:37:28 GMT ~ Celgene Receives Positive CHMP Opinion for ABRAXANE® in Combination with Gemcitabine as Treatment for Patients with Metastatic Pancreatic Cancer
- BOUDRY, Switzerland--(BUSINESS WIRE)--Nov. 22, 2013-- Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Medicines Agency's (EMA): ...
read full: http://www.noodls.com/view/76BE042913567670AB...5D746A9D48
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=CELGZ&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=CELGZ...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CELGZ/company-info
Ticker: $CELGZ
OTC Market Place: Not Available
CIK code: 0000816284
Company name: Celgene Corp.
Company website: http://www.celgene.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/CELGZ/filings
Latest financials: http://www.otcmarkets.com/stock/CELGZ/financials
Latest news: http://www.otcmarkets.com/stock/CELGZ/news - http://finance.yahoo.com/q/h?s=CELGZ+Headlines
Major holdings: http://data.cnbc.com/quotes/CELGZ/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=CELGZ+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/CELGZ.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=CELGZ
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Celgene+Corp.&...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...lgene+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.celgene.com
Alexa: http://www.alexa.com/siteinfo/http://www.celgene.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.celgene.com
http://www.pennystocktweets.com/stocks/profile/CELGZ
##### last known share structure ~ source: otcmarkets.com
Market Value: $87,087,186 a/o Dec 11, 2013
Shares Outstanding: 40,507,552 a/o Oct 07, 2010
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/CELGZ
$CELGZ
DD Notes ~ http://www.ddnotesmaker.com/CELGZ
##### recent news/filings ~ source: finance.yahoo.com
Wed, 11 Dec 2013 00:32:11 GMT ~ Studies Evaluating REVLIMID® (Lenalidomide) in Lymphoma Presented at ASH
- Two studies detail R2CHOP in elderly untreated patients and R2 as maintenance in patients with diffuse large B-cell lymphoma Third study evaluated R2 in previously-treated patients with indolent or mantle ...
read full: http://www.noodls.com/view/4474EF18497823644E...DD2A39710B
*********************************************************
Tue, 10 Dec 2013 14:11:09 GMT ~ Two Studies Highlight Retrospective Analyses of Phase III Study of POMALYST®/IMNOVID® (Pomalidomide) in Previously Treated Multiple Myeloma Patients Presented at ASH
- Studies evaluated effects of high-risk cytogenetics and prior therapies on outcomes BOUDRY, Switzerland--(BUSINESS WIRE)--Dec. 10, 2013-- Celgene International Sàrl, a wholly-owned subsidiary of Celgene ...
read full: http://www.noodls.com/view/E4CD928E2815561B07...6548927AA3
*********************************************************
Tue, 10 Dec 2013 01:41:33 GMT ~ REVLIMID® (lenalidomide)-Treated Patients with Deletion-5q MDS Who Achieve Transfusion-Independence of At Least 26 Weeks and AML-Free Survival Associated with Cytogenetic Response
- Retrospective analysis presented at American Society of Hematology annual meeting BOUDRY, Switzerland--(BUSINESS WIRE)--Dec. 9, 2013-- Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation ...
read full: http://www.noodls.com/view/4FB0753A257498D89E...3334BD9AE3
*********************************************************
Sun, 08 Dec 2013 03:33:10 GMT ~ First Analysis of Extended Dosing with Celgene Epigenetic Agent CC-486 in Patients with Higher-Risk Myelodysplastic Syndromes Presented at ASH
- BOUDRY, Switzerland--(BUSINESS WIRE)--Dec. 7, 2013-- Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG) today announced that results from an ad hoc analysis of a ...
read full: http://www.noodls.com/view/512000B61C7AA8DC53...A2DF7DA0A1
*********************************************************
Fri, 22 Nov 2013 13:37:28 GMT ~ Celgene Receives Positive CHMP Opinion for ABRAXANE® in Combination with Gemcitabine as Treatment for Patients with Metastatic Pancreatic Cancer
- BOUDRY, Switzerland--(BUSINESS WIRE)--Nov. 22, 2013-- Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Medicines Agency's (EMA): ...
read full: http://www.noodls.com/view/76BE042913567670AB...5D746A9D48
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=CELGZ&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=CELGZ...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CELGZ/company-info
Ticker: $CELGZ
OTC Market Place: Not Available
CIK code: 0000816284
Company name: Celgene Corp.
Company website: http://www.celgene.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/CELGZ/filings
Latest financials: http://www.otcmarkets.com/stock/CELGZ/financials
Latest news: http://www.otcmarkets.com/stock/CELGZ/news - http://finance.yahoo.com/q/h?s=CELGZ+Headlines
Major holdings: http://data.cnbc.com/quotes/CELGZ/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=CELGZ+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/CELGZ.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=CELGZ
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Celgene+Corp.&...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...lgene+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.celgene.com
Alexa: http://www.alexa.com/siteinfo/http://www.celgene.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.celgene.com
http://www.pennystocktweets.com/stocks/profile/CELGZ
##### last known share structure ~ source: otcmarkets.com
Market Value: $87,087,186 a/o Dec 11, 2013
Shares Outstanding: 40,507,552 a/o Oct 07, 2010
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/CELGZ
(0)
(0)Scroll down for more posts ▼
